secwatch.observer — SEC 8-K summary
======================================

Issuer:     SERA PROGNOSTICS, INC. (SERA)
CIK:        0001534969
Form:       8-K
Filed at:   2021-11-09T23:59:59+00:00
Accession:  0001534969-21-000017
Event type: earnings
Sentiment:  negative
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sera Prognostics Q3 net loss widens to $9.9M; cash $82.5M; salesforce scaling to 26 reps
--------------------------------------------------------------------------------

- Revenue $23K vs $5K YoY; net loss $9.9M vs $5.1M YoY.
- Operating expenses $9.5M (R&D $2.7M, SG&A $6.7M) up from $4.6M due to scaling commercial ops and public company costs.
- Cash & equivalents $82.5M plus $67.5M available-for-sale securities.
- Salesforce now 26 reps; appointed Paul Kearney as Chief Data Officer, Zhenya Lindgardt to Board, Woodrow Myers as advisor.
- Published health economic study showing PreTRM test could reduce $54M in costs; clinical validation study published.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1534969/000153496921000017/0001534969-21-000017-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1534969/000153496921000017/sera-20211109.htm
  HTML page:      https://secwatch.observer/filing/0001534969-21-000017

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer